Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Key Laboratory of Cardiovascular Epidemiology, Chinese Academy of Medical Sciences, Beijing, China.
JAMA Netw Open. 2023 Mar 1;6(3):e235565. doi: 10.1001/jamanetworkopen.2023.5565.
Blood lipids are the primary cause of atherosclerosis. However, little is known about relationships between rates of blood lipid changes and age and genetic risk.
To evaluate associations of blood lipid change rates with age and polygenic risk.
DESIGN, SETTING, AND PARTICIPANTS: This cohort is from the Prediction for Atherosclerotic Cardiovascular Disease Risk in China, which was established from 1998 to 2008. Participants were followed up until 2020 (mean [SD] follow-up, 13.8 [4.3] years) and received 4 repeated lipid measurements. Data analysis was performed from June to August 2022. A total of 47 691 participants with available genotype data were recruited, and 37 317 participants aged 18 years or older were included in the final analysis after excluding participants who were lost to follow-up or with major chronic diseases, and those without blood lipid measurements at baseline and any follow-up survey.
Age and polygenic risk scores based on 126 lipid-related genetic variants.
The estimated annual changes (EAC) of blood lipids in milligrams per deciliter.
This study evaluated 37 317 participants (mean [SD] age of 51.37 [10.82] years; 15 664 [41.98%] were male). The associations of EACs of blood lipids with age differed substantially between male and female participants. Male participants experienced declining change as they got older for total cholesterol (EAC, 0.34 [95% CI, 0.14 to 0.54] mg/dL for age <40 years vs 0.01 [95% CI, -0.11 to 0.13] mg/dL for age ≥60 years), triglyceride (EAC, 3.28 [95% CI, 2.50 to 4.07] mg/dL for age <40 years vs -1.70 [95% CI, -2.02 to -1.38] mg/dL for age ≥60 years), and low-density lipoprotein cholesterol (LDL-C) (EAC, 0.15 [95% CI, -0.02 to 0.32] mg/dL for age <40 years vs 0.01 [95% CI, -0.10 to 0.11] mg/dL for age ≥60 years). Female participants had inverse V-shaped associations and the greatest rate of change appeared in the age group of 40 to 49 years (EAC for total cholesterol, 1.33 [95% CI, 1.22 to 1.44] mg/dL; EAC for triglyceride, 2.28 [95% CI, 1.94 to 2.62] mg/dL; and EAC for LDL-C, 0.94 [95% CI, 0.84 to 1.03] mg/dL). Change in levels of blood lipids were also associated with polygenic risk. Participants at low polygenic risk tended to shift toward lower blood lipid levels, with EACs of -0.16 (95% CI, -0.25 to -0.07) mg/dL; -1.58 (95% CI, -1.78 to -1.37) mg/dL; and -0.13 (95% CI, -0.21 to -0.06) mg/dL for total cholesterol, triglyceride, and LDL-C, respectively. Participants with high polygenic risk had the greatest rates of change for total cholesterol, triglyceride, and LDL-C (EAC, 1.12 [95% CI, 1.03 to 1.21] mg/dL; EAC, 3.57 [95% CI, 3.24 to 3.91] mg/dL; and EAC, 0.73 [95% CI, 0.65 to 0.81] mg/dL, respectively). Similar patterns were also observed across sex and age groups.
In this cohort study, EACs of blood lipids were significantly associated with age and polygenic risk, suggesting that prevention strategies for lipids should focus on individuals with high genetic risk and in the critical age window.
重要性:血脂是动脉粥样硬化的主要原因。然而,人们对血脂变化率与年龄和遗传风险之间的关系知之甚少。
目的:评估血脂变化率与年龄和多基因风险的关联。
设计、地点和参与者:该队列来自于 1998 年至 2008 年建立的中国预测动脉粥样硬化性心血管疾病风险研究。参与者随访至 2020 年(平均[标准差]随访时间为 13.8[4.3]年),共接受了 4 次重复血脂测量。数据分析于 2022 年 6 月至 8 月进行。共招募了 47691 名有可用基因型数据的参与者,排除失访或患有重大慢性疾病的参与者,以及基线和任何随访调查均无血脂测量值的参与者后,最终有 37317 名年龄在 18 岁及以上的参与者纳入最终分析。
暴露因素:年龄和基于 126 个血脂相关遗传变异的多基因风险评分。
主要结局和测量指标:每毫克每分升的血脂年估计变化量(EAC)。
结果:本研究评估了 37317 名参与者(平均[标准差]年龄为 51.37[10.82]岁;15664[41.98%]为男性)。男性和女性参与者的血脂 EAC 与年龄的关联差异很大。男性参与者随着年龄的增长,总胆固醇呈下降趋势(年龄<40 岁时的 EAC 为 0.34[95%置信区间,0.14 至 0.54]mg/dL,年龄≥60 岁时为 0.01[95%置信区间,-0.11 至 0.13]mg/dL),甘油三酯(年龄<40 岁时的 EAC 为 3.28[95%置信区间,2.50 至 4.07]mg/dL,年龄≥60 岁时为-1.70[95%置信区间,-2.02 至-1.38]mg/dL)和低密度脂蛋白胆固醇(LDL-C)(年龄<40 岁时的 EAC 为 0.15[95%置信区间,0.02 至 0.32]mg/dL,年龄≥60 岁时为 0.01[95%置信区间,-0.10 至 0.11]mg/dL)。女性参与者呈反 V 形关联,最大变化率出现在 40 至 49 岁年龄组(总胆固醇 EAC 为 1.33[95%置信区间,1.22 至 1.44]mg/dL;甘油三酯 EAC 为 2.28[95%置信区间,1.94 至 2.62]mg/dL;LDL-C EAC 为 0.94[95%置信区间,0.84 至 1.03]mg/dL)。血脂水平的变化也与多基因风险相关。低多基因风险组的参与者倾向于血脂水平降低,总胆固醇 EAC 为-0.16(95%置信区间,-0.25 至-0.07)mg/dL;甘油三酯 EAC 为-1.58(95%置信区间,-1.78 至-1.37)mg/dL;LDL-C EAC 为-0.13(95%置信区间,-0.21 至-0.06)mg/dL。高多基因风险组的参与者的总胆固醇、甘油三酯和 LDL-C 变化率最大(EAC 分别为 1.12[95%置信区间,1.03 至 1.21]mg/dL;EAC 为 3.57[95%置信区间,3.24 至 3.91]mg/dL;EAC 为 0.73[95%置信区间,0.65 至 0.81]mg/dL)。在性别和年龄组中也观察到类似的模式。
结论:在这项队列研究中,血脂 EAC 与年龄和多基因风险显著相关,提示脂质预防策略应针对高遗传风险个体和关键年龄窗口。